High dose of dexamethasone protects against EAE-induced motor deficits but impairs learning/memory in C57BL/6 mice

Autor: Carolina Demarchi Munhoz, Guilherme Dragunas, Jennifer R Rodrigues, Leonardo S. Novaes, Jean Pierre Schatzmann Peron, Nilton Nascimento Dos Santos, Rosana Camarini, Wesley Nogueira Brandão
Přispěvatelé: Molecular Pharmacology
Rok vydání: 2019
Předmět:
0301 basic medicine
medicine.medical_specialty
Encephalomyelitis
Autoimmune
Experimental

Multiple Sclerosis
Motor Disorders
Central nervous system
Anti-Inflammatory Agents
Fluorescent Antibody Technique
lcsh:Medicine
Hippocampus
Molecular neuroscience
Dexamethasone
Article
Myelin oligodendrocyte glycoprotein
Mice
03 medical and health sciences
Receptors
Glucocorticoid

0302 clinical medicine
Glucocorticoid receptor
Memory
MEDICAMENTO
Internal medicine
medicine
Animals
Learning
lcsh:Science
Neuroinflammation
Multidisciplinary
biology
business.industry
Multiple sclerosis
lcsh:R
Experimental autoimmune encephalomyelitis
medicine.disease
Mice
Inbred C57BL

Disease Models
Animal

030104 developmental biology
Endocrinology
medicine.anatomical_structure
Spinal Cord
biology.protein
lcsh:Q
Memory consolidation
Corticosterone
business
hormones
hormone substitutes
and hormone antagonists

030217 neurology & neurosurgery
Zdroj: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Scientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
Scientific Reports, 9(1). Nature Publishing Group
Scientific Reports
ISSN: 2045-2322
DOI: 10.1038/s41598-019-43217-3
Popis: Multiple sclerosis (MS) is an autoimmune and neuroinflammatory disease characterized by demyelination of the Central Nervous System. Immune cells activation and release of pro-inflammatory cytokines play a crucial role in the disease modulation, decisively contributing to the neurodegeneration observed in MS and the experimental autoimmune encephalomyelitis (EAE), the widely used MS animal model. Synthetic glucocorticoids, commonly used to treat the MS attacks, have controversial effects on neuroinflammation and cognition. We sought to verify the influence of dexamethasone (DEX) on the EAE progression and on EAE-induced cognitive deficits. In myelin oligodendrocyte glycoprotein peptide (MOG35-55)-induced EAE female mice, treated once with DEX (50 mg/kg) or not, on the day of immunization, DEX decreased EAE-induced motor clinical scores, infiltrating cells in the spinal cord and delayed serum corticosterone peak. At the asymptomatic phase (8-day post-immunization), DEX did not protected from the EAE-induced memory consolidation deficits, which were accompanied by increased glucocorticoid receptor (GR) activity and decreased EGR-1 expression in the hippocampus. Blunting hippocampal GR genomic activation with DnGR vectors prevented DEX effects on EAE-induced memory impairment. These data suggest that, although DEX improves clinical signs, it decreases cognitive and memory capacity by diminishing neuronal activity and potentiating some aspects of neuroinflammation in EAE.
Databáze: OpenAIRE